CD14 and ovarian carcinoma: We reported the presence of a proangiogenic myeloid cell population, expressing numerous myeloid (CD14, CD45, CD11c, CD11b) and vascular (VE-Cadherin, CD31, CD146) surface markers, in ovarian cancer [21].